Latest News

Blocking key enzyme minimizes stroke injury, research finds

A drug that blocks the action of the enzyme Cdk5 could substantially reduce brain damage if administered shortly after a stroke, research suggests. The development of a Cdk5 inhibitor as an acute neuroprotective therapy has the potential to reduce stroke injury, researchers report.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Age-related cognitive decline tied to immune-system molecule

  • New study again shows: More strokes with intracranial stents

  • People over 65 with traumatic brain injuries hospitalized four times as often as younger people

  • Uncovering the mechanism of our oldest anesthetic

  • Researchers discover ways to regenerate corticospinal tract axons

  • Health information causing new moms anxiety

  • Learning from biology to accelerate discovery

  • Emotion knowledge fosters attentiveness

  • Research breakthrough to treat girls-only epilepsy

  • Safer, with more benefits: Parents' vaccine views shifting

  •